Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 5;25(1):69.
doi: 10.1186/s12931-024-02694-5.

Role of multidrug-resistant bacteria in weaning from invasive mechanical ventilation

Julia D Michels-Zetsche  1 , Vicky Gassmann  2 , Jasmin K Jasuja  3 , Benjamin Neetz  2 , Philipp Höger  2 , Jan Meis  4 , Simone Britsch  5 , Urte Sommerwerck  6 , Sebastian Fähndrich  7 , Florian Bornitz  8 , Michael M Müller  2 , Felix J F Herth  2 , Franziska C Trudzinski  2
Affiliations

Role of multidrug-resistant bacteria in weaning from invasive mechanical ventilation

Julia D Michels-Zetsche et al. Respir Res. .

Abstract

Background: Although multidrug-resistant bacteria (MDR) are common in patients undergoing prolonged weaning, there is little data on their impact on weaning and patient outcomes.

Methods: This is a retrospective analysis of consecutive patients who underwent prolonged weaning and were at a university weaning centre from January 2018 to December 2020. The influence of MDR colonisation and infection on weaning success (category 3a and 3b), successful prolonged weaning from invasive mechanical ventilation (IMV) with or without the need for non-invasive ventilation (NIV) compared with category 3c (weaning failure 3cI or death 3cII) was investigated. The pathogen groups considered were: multidrug-resistant gram-negative bacteria (MDRGN), methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus spp. (VRE).

Results: A total of 206 patients were studied, of whom 91 (44.2%) showed evidence of MDR bacteria (32% VRE, 1.5% MRSA and 16% MDRGN), with 25 patients also meeting the criteria for MDR infection. 70.9% of the 206 patients were successfully weaned from IMV, 8.7% died. In 72.2% of cases, nosocomial pneumonia and other infections were the main cause of death. Patients with evidence of MDR (infection and colonisation) had a higher incidence of weaning failure than those without evidence of MDR (48% vs. 34.8% vs. 21.7%). In multivariate analyses, MDR infection (OR 4.9, p = 0.004) was an independent risk factor for weaning failure, along with male sex (OR 2.3, p = 0.025), Charlson Comorbidity Index (OR 1.2, p = 0.027), pH (OR 2.7, p < 0.001) and duration of IMV before admission (OR 1.01, p < 0.001). In addition, MDR infection was the only independent risk factor for death (category 3cII), (OR 6.66, p = 0.007).

Conclusion: Patients with MDR infection are significantly more likely to die during the weaning process. There is an urgent need to develop non-antibiotic approaches for the prevention and treatment of MDR infections as well as clinical research on antibiotic stewardship in prolonged weaning as well as in ICUs.

Keywords: Mortality in weaning; Multidrug-resistant bacteria; Prolonged weaning; Weaning; Weaning failure.

PubMed Disclaimer

Conflict of interest statement

Julia D. Michels, Benjamin Neetz, Jan N. Meis, Simone Britsch, Florian Bornitz, Michael M. Müller, Felix J.F. Herth and Franziska C. Trudzinski report a relationship with Federal Joint Committee of Doctors Hospitals and Health Insurers that includes: funding grants for the PRiVENT project.

References

    1. WeanNet Study G. [WeanNet: the network of weaning units of the DGP (Deutsche Gesellschaft fur pneumologie und Beatmungsmedizin) - results to epidemiology an outcome in patients with prolonged weaning] Dtsch Med Wochenschr. 2016;141(18):e166–172. - PubMed
    1. Timsit JF, Bassetti M, Cremer O, Daikos G, de Waele J, Kallil A, Kipnis E, Kollef M, Laupland K, Paiva JA, Rodriguez-Bano J, Ruppe E, Salluh J, Taccone FS, Weiss E, Barbier F. Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med. 2019;45(2):172–89. doi: 10.1007/s00134-019-05520-5. - DOI - PubMed
    1. Tacconelli E, Gorska A, De Angelis G, Lammens C, Restuccia G, Schrenzel J, Huson DH, Carevic B, Preotescu L, Carmeli Y, Kazma M, Spanu T, Carrara E, Malhotra-Kumar S, Gladstone BP. Estimating the association between antibiotic exposure and colonization with extended-spectrum beta-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study. Clin Microbiol Infect. 2020;26(1):87–94. doi: 10.1016/j.cmi.2019.05.013. - DOI - PubMed
    1. Dantas LF, Dalmas B, Andrade RM, Hamacher S, Bozza FA. Predicting acquisition of carbapenem-resistant Gram-negative pathogens in intensive care units. J Hosp Infect. 2019;103(2):121–7. doi: 10.1016/j.jhin.2019.04.013. - DOI - PubMed
    1. Pop-Vicas A, Mitchell SL, Kandel R, Schreiber R, D’Agata EM. Multidrug-resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. J Am Geriatr Soc. 2008;56(7):1276–80. doi: 10.1111/j.1532-5415.2008.01787.x. - DOI - PubMed

Substances